• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

CBS:GR

0.001 EUR 0.0000.00%

As of 02:56:33 ET on 07/18/2014.

Snapshot for Acuvax Ltd (CBS)

Open: 0.001 Day's Range: 0.001 - 0.001 Volume: 0
Previous Close: 0.001 52wk Range: 0.001 - 0.001 1-Yr Rtn: -

Stock Chart for CBS

No chart data available.
  • CBS:GR 0.001
  • 1D
  • 1M
  • 1Y
0.001
Interactive CBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CBS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 2.63
Shares Outstanding (M) 2,632.97
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CBS

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for CBS

Acuvax Limited offers research and development of cancer therapies and vaccines in Australia and North America. The Company develops vaccines against debilitating infectious diseases such as dengue and west nile virus.

Roland Holger BerzinsSecretary
More Company Profile & Key Executives for CBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil